DS
BNTX icon

David Shaw’s BioNTech BNTX Stock Holding History

David Shaw’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Hold
65,000
– – ﹤0.01% 2248
2026
Q1 		$5.78M Sell
65,000
-6,000
-8% -$617K ﹤0.01% 2071
2025
Q4 		$6.76M Buy
71,000
+39,000
+122% +$3.93M ﹤0.01% 2073
2025
Q3 		$3.16M Sell
32,000
-5,000
-14% -$535K ﹤0.01% 2594
2025
Q2 		$3.94M Sell
37,000
-36,000
-49% -$3.64M ﹤0.01% 2206
2025
Q1 		$6.65M Sell
73,000
-126,500
-63% -$14.2M 0.01% 1690
2024
Q4 		$22.7M Sell
199,500
-1,300
-0.6% -$148K 0.02% 961
2024
Q3 		$23.8M Buy
200,800
+17,000
+9% +$1.56M 0.02% 897
2024
Q2 		$14.8M Sell
183,800
-1,500
-0.8% -$137K 0.01% 1082
2024
Q1 		$17.1M Buy
185,300
+700
+0.4% +$67.1K 0.01% 1010
2023
Q4 		$19.5M Hold
184,600
– – 0.02% 939
2023
Q3 		$20.1M Buy
184,600
+25,200
+16% +$2.79M 0.02% 859
2023
Q2 		$17.2M Buy
159,400
+129,400
+431% +$14.6M 0.02% 964
2023
Q1 		$3.74M Sell
30,000
-75,000
-71% -$10.3M ﹤0.01% 2194
2022
Q4 		$15.8M Hold
105,000
– – 0.02% 1078
2022
Q3 		$14.2M Sell
105,000
-33,100
-24% -$5.06M 0.02% 1085
2022
Q2 		$20.6M Sell
138,100
-91,400
-40% -$14M 0.02% 853
2022
Q1 		$39.1M Sell
229,500
-105,800
-32% -$17.8M 0.04% 606
2021
Q4 		$86.4M Buy
335,300
+110,000
+49% +$30.1M 0.07% 323
2021
Q3 		$61.5M Buy
225,300
+75,800
+51% +$24.1M 0.06% 434
2021
Q2 		$33.5M Buy
149,500
+129,500
+648% +$24.4M 0.03% 745
2021
Q1 		$2.18M Buy
+20,000
New +$2.12M ﹤0.01% 2511

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

David Shaw's BNTX Position: Q2 2026 in Review

David Shaw increased its BioNTech (BNTX) stake by 109% in Q2 2026, buying an estimated $20.5M and bringing the position to 417,421 shares worth $38.8M. The position accounts for 0.02% of the portfolio, ranked #899.

David Shaw first reported a position in BNTX in Q4 2020 and has held it in 21 quarters since. The position peaked at $103M in Q1 2022. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • David Shaw held 417,421 shares of BioNTech worth $38.8M as of Q2 2026.
  • David Shaw bought 217,653 BioNTech shares in Q2 2026, an estimated $20.5M.
  • BioNTech made up 0.02% of David Shaw's portfolio in Q2 2026, its #899 holding.
  • David Shaw first reported a position in BioNTech in Q4 2020 and has held it in 21 quarters since.
  • David Shaw's BioNTech position peaked at $103M in Q1 2022.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.